Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.
BACKGROUND:A vaccine against schistosomiasis would have a great impact in disease elimination. Sm29 and Sm22.6 are two parasite tegument proteins which represent promising antigens to compose a vaccine. These antigens have been associated with resistance to infection and reinfection in individuals l...
Saved in:
Main Authors: | Clarice Carvalho Alves (Author), Neusa Araujo (Author), Viviane Cristina Fernandes dos Santos (Author), Flávia Bubula Couto (Author), Natan R G Assis (Author), Suellen B Morais (Author), Sérgio Costa Oliveira (Author), Cristina Toscano Fonseca (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7.
by: Natalie Reimers, et al.
Published: (2015) -
Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs).
by: Jenna Shiels, et al.
Published: (2020) -
SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni.
by: Jan Dvorák, et al.
Published: (2009) -
Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
by: Fernanda C Cardoso, et al.
Published: (2008) -
Molecular characterization of the Schistosoma mansoni zinc finger protein SmZF1 as a transcription factor.
by: Marcela G Drummond, et al.
Published: (2009)